| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.0055 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |